P-269 * Phase II trial of Irinotecan/S-1 (IRIS) with...

Annals of Oncology 2015 / 06 Vol. 26; Iss. suppl 4

P-269 * Phase II trial of Irinotecan/S-1 (IRIS) with Cetuximab (IRIS/Cet) as second line treatment in patients with KRAS WT metastatic colorectal cancer: HGCSG0902. -Comparison of administration interval in Cetuximab treatment

Hatanaka, K., Yuki, S., Nakatsumi, H., Hosokawa, A., Nakamura, M., Muto, O., Meguro, T., Iwanaga, I., Tsuji, Y., Sato, A., Eto, K., Furukawa, K., Onodera, M., Tateyama, M., Takahashi, Y., Dazai, M., Y
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.266
Date:
June, 2015
File:
PDF, 35 KB
english, 2015
Conversion to is in progress
Conversion to is failed